Bruker Corporation (FRA:BKD)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	927.30M	938.50M
Germany Revenue	277.60M	310.70M
Rest of Europe Revenue	965.70M	873.00M
China Revenue	451.50M	471.20M
Rest of Asia Pacific Revenue	553.70M	518.50M
Total Asia Pacific Revenue	1.01B	989.70M
Other Countries Revenue	263.10M	254.50M
Revenue (Total)	3.44B	3.37B

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Revenue	884.20M	905.70M
BSI CALID Revenue	1.20B	1.09B
BSI Life Science Revenue	2.08B	2.00B
BSI Nano Revenue	1.09B	1.10B
Total BSI Revenue	3.18B	3.10B
BEST Revenue	271.50M	283.00M
Eliminations from Revenue	-9.50M	-14.10M
Revenue (Total)	3.44B	3.37B

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Operating Income	90.70M	157.80M
BSI CALID Operating Income	180.20M	180.00M
BSI Life Science Operating Income	270.90M	337.80M
BSI Nano Operating Income	-100.10M	2.30M
Corporate, Eliminations and Other Operating Income	-134.10M	-121.90M
Total BSI Operating Income	36.65M	218.20M
BEST Operating Income	27.30M	34.90M
Operating Income (Other)	-36.65M	-218.20M
Operating Income (Total)	64.00M	253.10M

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Capital Expenditures	22.80M
BSI CALID Capital Expenditures	34.10M
BSI Life Science Capital Expenditures	56.90M
BSI Nano Capital Expenditures	19.30M
Corporate Capital Expenditures	14.80M
Total BSI Capital Expenditures	91.00M
BEST Capital Expenditures	24.30M

Updated Sep 30, 2025. Data Source: Fiscal.ai.